OBJECTIVE: Discussing end-of-life (EOL) care is challenging when death is not imminent, contributing to poor decision-making and EOL quality-of-life. A communication support program (CSP) targeting these issues may facilitate discussions. We aimed to qualitatively explore responses to a nurse-led CSP, incorporating a question prompt list (QPL-booklet of questions patients/caregivers can ask clinicians), promoting life expectancy and EOL-care discussions. METHODS: Participants met a nurse-facilitator to explore an EOL-focussed QPL. Prognosis and advance care planning (ACP) QPL content was highlighted. Thirty-one transcribed meetings were analysed using thematic text analysis before reaching data saturation. RESULTS: Thirty-one advanced cancer patients (life expectancy <12 months) and 11 family caregivers were recruited from six medical oncology clinics in Sydney, Australia. Intent to use the QPL related to information needs, involvement in care and readiness to discuss EOL issues. Many participants did not want life expectancy estimates, citing unreliable estimates, unknown treatment outcomes, or coping by not looking ahead. Most displayed interest in ACP, often motivated by a loved one's EOL experiences, clear treatment preferences, concerns about caregivers or recognition that ACP is valuable regardless of life expectancy. Timing emerged as a reason not to discuss EOL issues; many maintaining it was too early. CONCLUSION: Patients and caregivers appear ambivalent about acknowledging approaching death by discussing life expectancy but value ACP. Given heterogeneity in responses, individualised approaches are required to guide EOL discussion conduct and content. Further exploration of the role of prognostic discussion in ACP is warranted.
OBJECTIVE: Discussing end-of-life (EOL) care is challenging when death is not imminent, contributing to poor decision-making and EOL quality-of-life. A communication support program (CSP) targeting these issues may facilitate discussions. We aimed to qualitatively explore responses to a nurse-led CSP, incorporating a question prompt list (QPL-booklet of questions patients/caregivers can ask clinicians), promoting life expectancy and EOL-care discussions. METHODS:Participants met a nurse-facilitator to explore an EOL-focussed QPL. Prognosis and advance care planning (ACP) QPL content was highlighted. Thirty-one transcribed meetings were analysed using thematic text analysis before reaching data saturation. RESULTS: Thirty-one advanced cancerpatients (life expectancy <12 months) and 11 family caregivers were recruited from six medical oncology clinics in Sydney, Australia. Intent to use the QPL related to information needs, involvement in care and readiness to discuss EOL issues. Many participants did not want life expectancy estimates, citing unreliable estimates, unknown treatment outcomes, or coping by not looking ahead. Most displayed interest in ACP, often motivated by a loved one's EOL experiences, clear treatment preferences, concerns about caregivers or recognition that ACP is valuable regardless of life expectancy. Timing emerged as a reason not to discuss EOL issues; many maintaining it was too early. CONCLUSION:Patients and caregivers appear ambivalent about acknowledging approaching death by discussing life expectancy but value ACP. Given heterogeneity in responses, individualised approaches are required to guide EOL discussion conduct and content. Further exploration of the role of prognostic discussion in ACP is warranted.
Authors: Monica E Lemmon; Hanna E Huffstetler; Pamela Donohue; Madelaine Katz; Mary C Barks; Emma Schindler; Debra Brandon; Renee D Boss; Peter A Ubel Journal: J Child Neurol Date: 2019-05-29 Impact factor: 1.987
Authors: Inge Henselmans; Hanneke W M van Laarhoven; Pomme van Maarschalkerweerd; Hanneke C J M de Haes; Marcel G W Dijkgraaf; Dirkje W Sommeijer; Petronella B Ottevanger; Helle-Brit Fiebrich; Serge Dohmen; Geert-Jan Creemers; Filip Y F L de Vos; Ellen M A Smets Journal: Oncologist Date: 2019-11-26
Authors: Joshua J Fenton; Paul R Duberstein; Richard L Kravitz; Guibo Xing; Daniel J Tancredi; Kevin Fiscella; Supriya Mohile; Ronald M Epstein Journal: J Clin Oncol Date: 2017-11-17 Impact factor: 44.544
Authors: Rachel A Rodenbach; Kim Brandes; Kevin Fiscella; Richard L Kravitz; Phyllis N Butow; Adam Walczak; Paul R Duberstein; Peter Sullivan; Beth Hoh; Guibo Xing; Sandy Plumb; Ronald M Epstein Journal: J Clin Oncol Date: 2017-01-30 Impact factor: 44.544
Authors: Martha A Cresswell; Carole A Robinson; Gillian Fyles; Joan L Bottorff; Rebecca Sudore Journal: Support Care Cancer Date: 2017-09-19 Impact factor: 3.603
Authors: Kate M Lillie; Lisa G Dirks; J Randall Curtis; Carey Candrian; Jean S Kutner; Jennifer L Shaw Journal: J Transcult Nurs Date: 2019-07-01 Impact factor: 1.959
Authors: Kah Poh Loh; Supriya G Mohile; Jennifer L Lund; Ronald Epstein; Lianlian Lei; Eva Culakova; Colin McHugh; Megan Wells; Nikesha Gilmore; Mostafa R Mohamed; Charles Kamen; Valerie Aarne; Alison Conlin; James Bearden; Adedayo Onitilo; Marsha Wittink; William Dale; Arti Hurria; Paul Duberstein Journal: Oncologist Date: 2019-04-23